does semaglutide cause strokes HUGE NEWS! Contrary to popular belief: GLP-1 weight loss medications are NOT all about aesthetics, they REDUCE risk of cardiovascular death, heart attack, stroke, heart failure, AND ALL MORTALITY! Groundbreaking SELECT GLP-1 receptor agonists in stroke
Description
Tirzepatide, a newer agent, received FDA approval in 2022 as Mounjaro for T2DM and was approved in 2023 for obesity [3]
Why Prescott Compounding Pharmacy
Obesity is a chronic condition that needs long-term management
doi: 10.1056/NEJMoa2028395 194 FangXDuZDuanCZhanSWangTZhuMet al
& Stehouwer, C
